Johnson & Johnson to Pay $2.2 Billion to Resolve Drug Marketing Allegations

Johnson & Johnson To Pay .2 Billion To Resolve Drug Marketing Allegations
Monday's action is the latest example of regulators cracking down on aggressive pharmaceutical marketing tactics, namely trying to increase sales by pushing medicines for unapproved, or "off-label," uses. While doctors are allowed to prescribe …
Read more on Huffington Post

Over-40s get more drug treatment
The overall number of people in treatment in England continued to fall in 2012/13, Public Health England said, as did the number of people starting treatment for heroin and crack cocaine. This reflects the overall decline in drug use, the authority added.
Read more on Hartlepool Mail